Evidence map›Paper›PMID 32550573›Full record

ArticleToxicon: X2019

The emerging field of venom-microbiomics for exploring venom as a microenvironment, and the corresponding Initiative for Venom Associated Microbes and Parasites (iVAMP).

Sabah Ul-Hasan, Eduardo Rodríguez-Román, Adam M Reitzel, Rachelle M M Adams, Volker Herzig, Clarissa J Nobile, Anthony J Saviola, Steven A Trim, Erin E Stiers, Sterghios A Moschos and 4 more

Open access · goldAbstract read
In one paragraph

Article in Toxicon: X, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Inhibition of bacterial biofilms by the snake venom proteome.Biotechnology reports (Amsterdam, Netherlands) · 2023
    Article
  10. Article
  11. Proteomics ofToxins · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Animal Venoms-Curse or Cure?Biomedicines · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 12 institutions in 5 countries.

Sabah Ul-HasanQuantitative and Systems Biology Graduate Program, University of California Merced, Merced, CA, 95343, USA.
Eduardo Rodríguez-RománCenter for Microbiology and Cell Biology, Venezuelan Institute for Scientific Research. Caracas, 1020A, Venezuela.
Adam M ReitzelDepartment of Biological Sciences, University of North Carolina at Charlotte, Charlotte, NC, 28223, USA.
Rachelle M M AdamsDepartment of Evolution, Ecology and Organismal Biology, The Ohio State University, Columbus, OH, 43212, USA.
Volker HerzigInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.
Clarissa J NobileDepartment of Molecular and Cell Biology, School of Natural Sciences, University of California Merced, Merced, CA, 95343, USA.
Anthony J SaviolaDepartment of Molecular Medicine and Neurobiology, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Steven A TrimVenomtech Ltd, Discovery Park, Sandwich, Kent, CT13 9ND, UK.
Erin E StiersDepartment of Biological Science, Clemson University, Clemson, SC, 29634, USA.
Sterghios A MoschosDepartment of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle, Tyne and Wear, NE1 8ST, UK.
Carl N KeiserDepartment of Biology, University of Florida, Gainesville, FL 32611, USA.
Daniel PetrasCollaborative Mass Spectrometry Innovation Center, University of California, San Diego, USA.
Yehu MoranDepartment of Ecology, Evolution and Behavior, Alexander Silberman Institute of Life Sciences, Faculty of Science, The Hebrew University of Jerusalem, Jerusalem, 9190401, Israel.
Timothy J ColstonDepartment of Biological Science, Florida State University, Tallahassee, FL 32306, USA.
University of California, Merced · USClemson University · USFlorida State University · USHebrew University of Jerusalem · ILInstituto Venezolano de Investigaciones Científicas · VENorthumbria University · GBScripps Institution of Oceanography · USScripps Research Institute · USThe Ohio State University · USUniversity of Florida · USUniversity of North Carolina at Charlotte · USUniversity of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Venom is a known source of novel antimicrobial natural products. The substantial, increasing number of these discoveries have unintentionally culminated in the misconception that venom and venom-producing glands are largely sterile environments. Culture-dependent and -independent studies on the microbial communities in venom microenvironments reveal the presence of archaea, algae, bacteria, fungi, protozoa, and viruses. Venom-centric microbiome studies are relatively sparse to date with the adaptive advantages that venom-associated microbes might offer to their hosts, or that hosts might provide to venom-associated microbes, remaining largely unknown. We highlight the potential for the discovery of venom microbiomes within the adaptive landscape of venom systems. The considerable number of convergently evolved venomous animals, juxtaposed with the comparatively few known studies to identify microbial communities in venom, provides new possibilities for both biodiversity and therapeutic discoveries. We present an evidence-based argument for integrating microbiology as part of venomics (i.e., venom-microbiomics) and introduce iVAMP, the Initiative for Venom Associated Microbes and Parasites (https://ivamp-consortium.github.io/), as a growing collaborative consortium. We express commitment to the diversity, inclusion and scientific collaboration among researchers interested in this emerging subdiscipline through expansion of the iVAMP consortium.

Indexed as

BacteriaCoevolutionHolobiontMicrobiomeSymbiontVirus

Identifiers

PMID32550573
PMCPMC7286055
OpenAlexW2973827970

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.